News & Updates
Filter by Specialty:
Sugary drinks raise dementia risk
People who regularly consume sugar-sweetened (SSBs) and artificially sweetened beverages (ASBs) appear to be at greater risk of dementia, but those who drink natural juices (NJs) in moderation show a reduced risk, suggests a study.
Sugary drinks raise dementia risk
27 Apr 2023AF screening tied to reduction in stroke risk in patients with high NT-proBNP
Screening for atrial fibrillation (AF) is associated with a reduction in the risk of stroke in individuals with a high NT-proBNP* level, according to a post hoc analysis of the LOOP study.
AF screening tied to reduction in stroke risk in patients with high NT-proBNP
26 Apr 2023Biofeedback-virtual reality device beneficial in chronic migraine
For individuals with chronic migraine, frequent use of a portable biofeedback-virtual reality device leads to a decreased frequency of acute analgesic drug use and an improvement in depression, as shown in a pilot study.
Biofeedback-virtual reality device beneficial in chronic migraine
18 Apr 2023IBD patients at higher risk of Alzheimer’s disease
Inflammatory bowel disease (IBD) shows an independent relationship with the development of Alzheimer’s disease (AD), with such association being stronger in patients with Crohn’s disease (CD) than those with ulcerative colitis (UC), reveals a study.
IBD patients at higher risk of Alzheimer’s disease
13 Apr 2023Exergaming improves neuronal activity and executive function in older adults with dementia
Findings of a small randomized trial in older adults with moderate dementia suggest that exergaming may be associated with greater improvements in brain neuronal activity and enhanced executive function task performance than regular aerobic exercise.
Exergaming improves neuronal activity and executive function in older adults with dementia
12 Apr 2023Early addition of cerebrolysin to reperfusion therapy reduces haemorrhagic transformation after ischaemic stroke
A prospective, randomized, multicentre pilot study finds that early addition of cerebrolysin to reperfusion therapy is safe and significantly reduces the rate of haemorrhagic transformation (HT) after acute ischaemic stroke (AIS).